Special clinical interests in prostate cancer, bladder cancer, brain tumours, skin cancer and radiotherapy for benign disease.Dr Shaffer specialises in using chemotherapy and radiotherapy to
Dr Shaffer specialises in using chemotherapy and radiotherapy to treat brain tumours, prostate and bladder cancer, and skin cancer.
He is a prominent UK expert at using radiotherapy for treating benign diseases including early Dupuytren’s disease, Ledderhose disease and plantar fasciitis. He co-wrote the 2015 Royal College of Radiologists guidelines on this subject.
Dr Shaffer’s research centred around radiotherapy planning studies comparing new types of advanced radiotherapy techniques in prostate, breast, high-grade glioma, and paediatric tumours. He has presented and been published widely in the oncology arena.
He is lead for Radiotherapy Innovation for GenesisCare UK. He has previously been chair of the IMRT-IGRT Radiotherapy Group, the Network Brain Tumour Working Group, Clinical Lead for Radiotherapy at St Luke’s Cancer Centre, and a trustee of the Fountain Centre (a local patient support charity).
In his early career, Dr Shaffer trained as a specialist registrar at various London teaching hospitals, and also completed a Clinical Fellowship in Radiation Oncology at the British Columbia Cancer Agency in Vancouver, Canada.
- Urological cancers
- Neurological cancers
- Dupuytren’s disease
- Ledderhose disease
NHS Hospital / current post(s)
- Consultant Clinical Oncologist, Royal Surrey County Hospital NHS Foundation Trust
- Consultant Clinical Oncologist, Hampshire Hospitals NHS Foundation Trust
- Principle investigator on a number of phase 3 clinical trials in brain and prostate cancer
- Member of the Royal College of Physicians
- Fellow of the Royal College of Radiologists